Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c02850 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2025. Written by Qinglian Hu and 5 co-authors. Institution: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China. Major MEDLINE topics: Probiotics, Immunotherapy, Colorectal Neoplasms, Phototherapy. Cited 11 times so far (Crossref); 45 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (original language)
Bioengineered probiotics enable new opportunities to address abnormal cancer metabolism and suppressive immune-environment interactions for improved therapeutic susceptibility. Here, Escherichia coli Nissle 1917 (EcN) was constructed to convert ammonia into l-arginine continuously and was further modified with polydopamine (PDA) to form living biotherapeutic argEcN@P for enhanced colorectal cancer eradication. Benefiting from the movement of EcN, argEcN@P could colonize and penetrate deep in tumors through hypoxia targeting and increase the intratumoral l-arginine concentrations. Upon near-infrared light (NIR) irradiation, heating induced by PDA could ablate tumor cells efficiently and release tumor antigens, which induce immunogenic cell death (ICD). More interestingly, argEcN@P remarkably promotes differentiation into M1-like macrophages in tumor tissues, inhibiting primary, distant tumor growth by inducing potent adaptive antitumor immunity. More importantly, argEcN@P treatment efficiently prevented postoperative tumor recurrence by inducing long-term immune memory. Taken together, this platform based on bioengineered probiotics provides a promising strategy for tumor metabolic reprogramming sensitized photothermal immunotherapy in deep tumors.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China.
ORCID profiles: Qinglian Hu, Dongchang Sun, Yuanxiang Jin
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Cite
APA
Hu, Q., Huang, X., Wang, T., Lu, Z., Sun, D., & Jin, Y. (2025). Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c02850
Vancouver
Hu Q, Huang X, Wang T, Lu Z, Sun D, Jin Y. Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c02850
BibTeX
@article{Hu2025,
author = {Hu, Qinglian and Huang, Xiaoyu and Wang, Tong and Lu, Zhuoting and Sun, Dongchang and Jin, Yuanxiang},
title = {Engineered Probiotics-Based Biohybrid-Driven Tumor Metabolic Remodeling To Boost Tumor Photoimmunotherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c02850}
}
EUVIMED